http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107573341-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcaf32dbc0d3ecbcd3951c09b65a2e58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059ad9a55233bf3be3ec0d9560242c8b |
| publicationDate | 2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107573341-A |
| titleOfInvention | Novel fused ring compound as PARP inhibitor, its preparation method and application |
| abstract | The invention discloses a novel condensed ring compound as a PARP inhibitor, its preparation method and application. The condensed ring compound of the present invention is shown in formula I. The fused ring compound of the present invention has PARP inhibitory activity, provides a new commercial option for PARP inhibitors, and can be used for treating and/or preventing tumors, stroke, myocardial ischemia, inflammation or diabetes. |
| priorityDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.